9.60
InMed Pharmaceuticals Inc.
Metrics score locked — part of Premium
FY22
FY23
FY24
FY25
FY26
FY22 – FY26
Assets
(positive)
Change from FY22 to FY26
millions USD
FY22:
FY23:
11.3
FY24:
8.69
FY25:
12.9
FY26:
2.68
(positive)
Change from FY22 to FY26
millions USD
FY22:
3.19
FY23:
2.77
FY24:
3.13
FY25:
2.71
FY26:
0.35
Total assets
Change from FY22 to FY26
millions USD
FY22:
12.8
FY23:
14.1
FY24:
11.8
FY25:
15.6
FY26:
3.03
Liabilities & Equity
(negative)
Change from FY22 to FY26
millions USD
FY22:
3.32
FY23:
2.00
FY24:
1.97
FY25:
1.84
FY26:
1.96
(negative)
Change from FY22 to FY26
millions USD
FY22:
0.39
FY23:
0.02
FY24:
0.64
FY25:
0.31
FY26:
0
(positive)
Change from FY22 to FY26
millions USD
FY22:
9.08
FY23:
12.1
FY24:
9.21
FY25:
13.4
FY26:
1.08
Total liabilities & equity
Change from FY22 to FY26
millions USD
FY22:
12.8
FY23:
14.1
FY24:
11.8
FY25:
15.6
FY26:
3.03
All amounts in millions USD